Growing community of inventors

Raritan, NJ, United States of America

Jihua Guan

Average Co-Inventor Count = 4.61

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 32

Jihua GuanZhihua Sui (8 patents)Jihua GuanJames C Lanter (7 patents)Jihua GuanRaymond C Ng (5 patents)Jihua GuanVernon C Alford, Jr (5 patents)Jihua GuanMark J Macielag (3 patents)Jihua GuanWeiqin Jiang (1 patent)Jihua GuanRaymond A Ng (5 patents)Jihua GuanWeigin Jiang (1 patent)Jihua GuanVernon C Alford (0 patent)Jihua GuanJihua Guan (8 patents)Zhihua SuiZhihua Sui (108 patents)James C LanterJames C Lanter (34 patents)Raymond C NgRaymond C Ng (15 patents)Vernon C Alford, JrVernon C Alford, Jr (9 patents)Mark J MacielagMark J Macielag (90 patents)Weiqin JiangWeiqin Jiang (18 patents)Raymond A NgRaymond A Ng (5 patents)Weigin JiangWeigin Jiang (1 patent)Vernon C AlfordVernon C Alford (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Janssen Pharmaceutica Nv (6 from 2,076 patents)

2. Other (1 from 832,680 patents)

3. Ortho-mcneil Pharmaceutical Corp. (1 from 363 patents)


8 patents:

1. 8586616 - Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)

2. 7879895 - Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)

3. 7795446 - Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)

4. 7566733 - Benzimidazole derivatives useful as selective androgen receptor modulators (sarms)

5. 7348438 - Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)

6. 6818646 - Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors

7. 6635638 - Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors

8. 6077841 - 5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…